Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Gemcitabine (NSC #613327) in Children With Relapsed Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

NCT00006462 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00006462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Gemcitabine (NSC #613327) in Children With Relapsed Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2001
Completion date
September 30, 2006
Enrollment
32 (actual)
Sites
225

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia